From: Clinical presentation and prognostic analysis of adult patients with Langerhans cell histiocytosis with pulmonary involvement
PFT, n (%)
Improvement
Deterioration
Stabilization
DLCO
2 (6.9)
25 (86.2)
FEV1
4 (13.8)
1 (3.4)
24 (82.8)
TLC
27 (93.1)
Overall
21 (72.4)